PACE GARY W
SEC CIK 1184778 · EDGAR
BoughtSold
Most active insiders at CRDF, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | PACE GARY W | Dir | $1.04M | — |
| 2 | Mohindru Mani | CEO, Dir | $79.9K | — |
Transactions 18
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-07-16 16:03 | 2026-07-14 | CRDF | Cardiff Oncology, Inc. | PACE GARY W | Dir | P - Purchase | $1.46 | +687.3K | 2.04M | +51% | +$1000.0K |
| 2026-06-22 09:00 | 2026-06-18 | CRDF | Cardiff Oncology, Inc. | PACE GARY W | Dir | P - Purchase | $1.22 | +30.0K | 1.36M | +2% | +$36.6K | |
| 2025-07-31 | 2025-07-30 | CRDF | Cardiff Oncology, Inc. | PACE GARY W | Dir | P - Purchase | $2.45 | +275.0K | 1.33M | +26% | +$673.8K | |
| I | 2025-07-31 | 2025-07-30 | CRDF | Cardiff Oncology, Inc. | PACE GARY W | Dir | P - Purchase | $2.45 | +15.0K | 1.35M | +1% | +$36.8K |
| I | 2024-12-12 | 2024-12-11 | CRDF | Cardiff Oncology, Inc. | PACE GARY W | Dir | P - Purchase | $2.60 | +11.5K | 1.06M | +1% | +$29.9K |
| 2024-12-12 | 2024-12-11 | CRDF | Cardiff Oncology, Inc. | PACE GARY W | Dir | P - Purchase | $2.60 | +350.1K | 1.05M | +50% | +$910.3K | |
| M | 2024-03-08 | 2024-03-06+ | PCRX | Pacira BioSciences, Inc. | PACE GARY W | Dir | S - Sale | $30.64 | -119.3K | 22.1K | -84% | -$3.66M |
| 2023-12-19 | 2023-12-19 | CRDF | Cardiff Oncology, Inc. | PACE GARY W | Dir | P - Purchase | $1.37 | +30.0K | 697.8K | +4% | +$41.1K | |
| 2023-11-14 | 2023-11-10 | CRDF | Cardiff Oncology, Inc. | PACE GARY W | Dir | P - Purchase | $0.98 | +22.9K | 667.8K | +4% | +$22.5K | |
| D | 2023-06-16 | 2023-06-14 | PCRX | Pacira BioSciences, Inc. | PACE GARY W | Dir | A - Grant | $0.00 | +1,775 | 141.4K | +1% | $0 |
| D | 2023-05-15 | 2023-05-11 | PCRX | Pacira BioSciences, Inc. | PACE GARY W | Dir | M - OptEx | $29.90 | +7,000 | 144.7K | +5% | +$209.3K |
| D | 2023-05-15 | 2023-05-11 | PCRX | Pacira BioSciences, Inc. | PACE GARY W | Dir | S - Sale+OE | $41.78 | -5,015 | 139.7K | -3% | -$209.5K |
| 2022-09-19 | 2022-09-15 | CRDF | Cardiff Oncology, Inc. | PACE GARY W | Dir | P - Purchase | $1.71 | +150.0K | 644.8K | +30% | +$256.5K | |
| D | 2022-06-08 | 2022-06-08 | PCRX | Pacira BioSciences, Inc. | PACE GARY W | Dir | A - Grant | $0.00 | +1,160 | 137.7K | +0.8% | $0 |
| D | 2022-03-07 | 2022-03-03 | PCRX | Pacira BioSciences, Inc. | PACE GARY W | Dir | M - OptEx | $10.81 | +7,000 | 136.5K | +5% | +$75.7K |
| DM | 2022-03-01 | 2022-02-28+ | PCRX | Pacira BioSciences, Inc. | PACE GARY W | Dir | S - Sale+OE | $66.87 | -30.0K | 129.5K | -19% | -$2.01M |
| DM | 2022-03-01 | 2022-02-28+ | PCRX | Pacira BioSciences, Inc. | PACE GARY W | Dir | M - OptEx | $11.02 | +30.0K | 139.3K | +27% | +$330.6K |
| 2021-09-22 | 2021-09-21 | CRDF | Cardiff Oncology, Inc. | PACE GARY W | Dir | P - Purchase | $6.75 | +30.0K | 494.8K | +6% | +$202.5K |
Purchase Sale Sale after option exercise All abbreviations